Global Intravenous Anticoagulants Production, Demand and Key Producers, 2022-2028

December 2022 | 110 pages | ID: GF456A11BC1FEN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Anticoagulants are medicines that prevent blood clots from forming and stop existing clots from growing bigger.

This report studies the global Intravenous Anticoagulants production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Intravenous Anticoagulants, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Intravenous Anticoagulants that contribute to its increasing demand across many markets.

The global Intravenous Anticoagulants market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).

Highlights and key features of the study

Global Intravenous Anticoagulants total production and demand, 2017-2028, (K Units)

Global Intravenous Anticoagulants total production value, 2017-2028, (USD Million)

Global Intravenous Anticoagulants production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)

Global Intravenous Anticoagulants consumption by region & country, CAGR, 2017-2028 & (K Units)

U.S. VS China: Intravenous Anticoagulants domestic production, consumption, key domestic manufacturers and share

Global Intravenous Anticoagulants production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)

Global Intravenous Anticoagulants production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)

Global Intravenous Anticoagulants production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)

This reports profiles key players in the global Intravenous Anticoagulants market based on the following parameters – headquarters, production locations, products portfolio, Intravenous Anticoagulants revenue, sales, average price and gross margin, recent developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Intravenous Anticoagulants market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.

Global Intravenous Anticoagulants Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
Global Intravenous Anticoagulants Market, Segmentation by Type
  • Low-Molecular-Weight Heparin (LMWH)
  • Direct Thrombin Inhibitor (DTI)
  • Others
Global Intravenous Anticoagulants Market, Segmentation by Application
  • Hospital
  • Clinic
  • Others
Companies Profiled:
  • Aspen Group
  • Pfizer
  • Sanofi
  • Mylan
  • Bayer AG
  • Boehringer Ingelheim
  • Daiichi Sankyo
  • Otsuka
  • Roche
  • The Medicines Company
  • Alexion
  • Leo Pharma
Key Questions Answered

1. How big is the global Intravenous Anticoagulants market?

2. What is the demand of the global Intravenous Anticoagulants market?

3. What is the year over year growth of the global Intravenous Anticoagulants market?

4. What is the production and production value of the global Intravenous Anticoagulants market?

5. Who are the key producers in the global Intravenous Anticoagulants market?

6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 Intravenous Anticoagulants Introduction
1.2 World Intravenous Anticoagulants Supply & Forecast
  1.2.1 World Intravenous Anticoagulants Production Value (2017 & 2021 & 2028)
  1.2.2 World Intravenous Anticoagulants Production (2017-2028)
  1.2.3 World Intravenous Anticoagulants Pricing Trends (2017-2028)
1.3 World Intravenous Anticoagulants Production by Region
  1.3.1 World Intravenous Anticoagulants Production Value by Region (2017-2028)
  1.3.2 World Intravenous Anticoagulants Production by Region (2017-2028)
  1.3.3 World Intravenous Anticoagulants Average Price by Region (2017-2028)
  1.3.4 North America Intravenous Anticoagulants Production (2017-2028)
  1.3.5 Europe Intravenous Anticoagulants Production (2017-2028)
  1.3.6 China Intravenous Anticoagulants Production (2017-2028)
  1.3.7 Japan Intravenous Anticoagulants Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Intravenous Anticoagulants Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Intravenous Anticoagulants Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Intravenous Anticoagulants Demand (2017-2028)
2.2 World Intravenous Anticoagulants Consumption by Region
  2.2.1 World Intravenous Anticoagulants Consumption by Region (2017-2022)
  2.2.2 World Intravenous Anticoagulants Consumption Forecast by Region (2023-2028)
2.3 United States Intravenous Anticoagulants Consumption (2017-2028)
2.4 China Intravenous Anticoagulants Consumption (2017-2028)
2.5 Europe Intravenous Anticoagulants Consumption (2017-2028)
2.6 Japan Intravenous Anticoagulants Consumption (2017-2028)
2.7 South Korea Intravenous Anticoagulants Consumption (2017-2028)
2.8 ASEAN Intravenous Anticoagulants Consumption (2017-2028)
2.9 India Intravenous Anticoagulants Consumption (2017-2028)

3 WORLD INTRAVENOUS ANTICOAGULANTS MANUFACTURERS COMPETITIVE ANALYSIS

3.1 World Intravenous Anticoagulants Production Value by Manufacturer (2017-2022)
3.2 World Intravenous Anticoagulants Production by Manufacturer (2017-2022)
3.3 World Intravenous Anticoagulants Average Price by Manufacturer (2017-2022)
3.4 Intravenous Anticoagulants Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
  3.5.1 Global Intravenous Anticoagulants Industry Rank of Major Manufacturers
  3.5.2 Global Concentration Ratios (CR4) for Intravenous Anticoagulants in 2021
  3.5.3 Global Concentration Ratios (CR8) for Intravenous Anticoagulants in 2021
3.6 Intravenous Anticoagulants Market: Overall Company Footprint Analysis
  3.6.1 Intravenous Anticoagulants Market: Region Footprint
  3.6.2 Intravenous Anticoagulants Market: Company Product Type Footprint
  3.6.3 Intravenous Anticoagulants Market: Company Product Application Footprint
3.7 Competitive Environment
  3.7.1 Historical Structure of the Industry
  3.7.2 Barriers of Market Entry
  3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 UNITED STATES VS CHINA VS REST OF THE WORLD

4.1 United States VS China: Intravenous Anticoagulants Production Value Comparison
  4.1.1 United States VS China: Intravenous Anticoagulants Production Value Comparison (2017 & 2021 & 2028)
  4.1.2 United States VS China: Intravenous Anticoagulants Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Intravenous Anticoagulants Production Comparison
  4.2.1 United States VS China: Intravenous Anticoagulants Production Comparison (2017 & 2021 & 2028)
  4.2.2 United States VS China: Intravenous Anticoagulants Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Intravenous Anticoagulants Consumption Comparison
  4.3.1 United States VS China: Intravenous Anticoagulants Consumption Comparison (2017 & 2021 & 2028)
  4.3.2 United States VS China: Intravenous Anticoagulants Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Intravenous Anticoagulants Key Producers and Market Share, 2017-2022
  4.4.1 Major Manufacturer of Intravenous Anticoagulants in United States, Company Headquarters and Production Place (States, Country)
  4.4.2 United States Intravenous Anticoagulants Production Value by Domestic Manufacturer, (2017-2022)
  4.4.3 United States Intravenous Anticoagulants Production by Domestic Manufacturer, (2017-2022)
4.5 China Intravenous Anticoagulants Key Producers and Market Share, 2017-2022
  4.5.1 Major Manufacturer of Intravenous Anticoagulants in China, Company Headquarters and Production Place (Province, Country)
  4.5.2 China Intravenous Anticoagulants Production Value by Domestic Manufacturer, (2017-2022)
  4.5.3 China Intravenous Anticoagulants Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Intravenous Anticoagulants Key Producers and Market Share, 2017-2022
  4.6.1 Major Manufacturer of Intravenous Anticoagulants in Rest of World, Company Headquarters and Production Place (State, Country)
  4.6.2 Rest of World Intravenous Anticoagulants Production Value by Domestic Manufacturer, (2017-2022)
  4.6.3 Rest of World Intravenous Anticoagulants Production by Domestic Manufacturer, (2017-2022)

5 MARKET ANALYSIS BY TYPE

5.1 World Intravenous Anticoagulants Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
  5.2.1 Low-Molecular-Weight Heparin (LMWH)
  5.2.2 Direct Thrombin Inhibitor (DTI)
  5.2.3 Others
5.3 Market Segment by Type
  5.3.1 World Intravenous Anticoagulants Production by Type (2017-2028)
  5.3.2 World Intravenous Anticoagulants Production Value by Type (2017-2028)
  5.3.3 World Intravenous Anticoagulants Average Price by Type (2017-2028)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Intravenous Anticoagulants Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
  6.2.1 Hospital
  6.2.2 Clinic
  6.2.3 Others
6.3 Market Segment by Application
  6.3.1 World Intravenous Anticoagulants Production by Application (2017-2028)
  6.3.2 World Intravenous Anticoagulants Production Value by Application (2017-2028)
  6.3.3 World Intravenous Anticoagulants Average Price by Application (2017-2028)

7 COMPANY PROFILES

7.1 Aspen Group
  7.1.1 Aspen Group Details
  7.1.2 Aspen Group Major Business
  7.1.3 Aspen Group Intravenous Anticoagulants Product and Services
  7.1.4 Aspen Group Intravenous Anticoagulants Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.1.5 Aspen Group Recent Developments/Updates
  7.1.6 Aspen Group Competitive Strengths & Weaknesses
7.2 Pfizer
  7.2.1 Pfizer Details
  7.2.2 Pfizer Major Business
  7.2.3 Pfizer Intravenous Anticoagulants Product and Services
  7.2.4 Pfizer Intravenous Anticoagulants Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.2.5 Pfizer Recent Developments/Updates
  7.2.6 Pfizer Competitive Strengths & Weaknesses
7.3 Sanofi
  7.3.1 Sanofi Details
  7.3.2 Sanofi Major Business
  7.3.3 Sanofi Intravenous Anticoagulants Product and Services
  7.3.4 Sanofi Intravenous Anticoagulants Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.3.5 Sanofi Recent Developments/Updates
  7.3.6 Sanofi Competitive Strengths & Weaknesses
7.4 Mylan
  7.4.1 Mylan Details
  7.4.2 Mylan Major Business
  7.4.3 Mylan Intravenous Anticoagulants Product and Services
  7.4.4 Mylan Intravenous Anticoagulants Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.4.5 Mylan Recent Developments/Updates
  7.4.6 Mylan Competitive Strengths & Weaknesses
7.5 Bayer AG
  7.5.1 Bayer AG Details
  7.5.2 Bayer AG Major Business
  7.5.3 Bayer AG Intravenous Anticoagulants Product and Services
  7.5.4 Bayer AG Intravenous Anticoagulants Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.5.5 Bayer AG Recent Developments/Updates
  7.5.6 Bayer AG Competitive Strengths & Weaknesses
7.6 Boehringer Ingelheim
  7.6.1 Boehringer Ingelheim Details
  7.6.2 Boehringer Ingelheim Major Business
  7.6.3 Boehringer Ingelheim Intravenous Anticoagulants Product and Services
  7.6.4 Boehringer Ingelheim Intravenous Anticoagulants Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.6.5 Boehringer Ingelheim Recent Developments/Updates
  7.6.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.7 Daiichi Sankyo
  7.7.1 Daiichi Sankyo Details
  7.7.2 Daiichi Sankyo Major Business
  7.7.3 Daiichi Sankyo Intravenous Anticoagulants Product and Services
  7.7.4 Daiichi Sankyo Intravenous Anticoagulants Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.7.5 Daiichi Sankyo Recent Developments/Updates
  7.7.6 Daiichi Sankyo Competitive Strengths & Weaknesses
7.8 Otsuka
  7.8.1 Otsuka Details
  7.8.2 Otsuka Major Business
  7.8.3 Otsuka Intravenous Anticoagulants Product and Services
  7.8.4 Otsuka Intravenous Anticoagulants Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.8.5 Otsuka Recent Developments/Updates
  7.8.6 Otsuka Competitive Strengths & Weaknesses
7.9 Roche
  7.9.1 Roche Details
  7.9.2 Roche Major Business
  7.9.3 Roche Intravenous Anticoagulants Product and Services
  7.9.4 Roche Intravenous Anticoagulants Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.9.5 Roche Recent Developments/Updates
  7.9.6 Roche Competitive Strengths & Weaknesses
7.10 The Medicines Company
  7.10.1 The Medicines Company Details
  7.10.2 The Medicines Company Major Business
  7.10.3 The Medicines Company Intravenous Anticoagulants Product and Services
  7.10.4 The Medicines Company Intravenous Anticoagulants Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.10.5 The Medicines Company Recent Developments/Updates
  7.10.6 The Medicines Company Competitive Strengths & Weaknesses
7.11 Alexion
  7.11.1 Alexion Details
  7.11.2 Alexion Major Business
  7.11.3 Alexion Intravenous Anticoagulants Product and Services
  7.11.4 Alexion Intravenous Anticoagulants Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.11.5 Alexion Recent Developments/Updates
  7.11.6 Alexion Competitive Strengths & Weaknesses
7.12 Leo Pharma
  7.12.1 Leo Pharma Details
  7.12.2 Leo Pharma Major Business
  7.12.3 Leo Pharma Intravenous Anticoagulants Product and Services
  7.12.4 Leo Pharma Intravenous Anticoagulants Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.12.5 Leo Pharma Recent Developments/Updates
  7.12.6 Leo Pharma Competitive Strengths & Weaknesses

8 RAW MATERIAL AND INDUSTRY CHAIN

8.1 Raw Material of Intravenous Anticoagulants and Key Manufacturers
8.2 Intravenous Anticoagulants Manufacturing Costs
8.3 Intravenous Anticoagulants Production Process
8.4 Intravenous Anticoagulants Industrial Chain

9 DISTRIBUTION CHANNEL ANALYSIS

9.1 Distribution Channel Breakdown for Intravenous Anticoagulants Shipments (%): 2017-2028
  9.1.1 Direct Channel
  9.1.2 Indirect Channel
9.2 Intravenous Anticoagulants Typical Distributors
9.3 Intravenous Anticoagulants Typical Customers

10 RESEARCH FINDINGS AND CONCLUSION

11 APPENDIX

11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer

LIST OF TABLES

Table 1. World Intravenous Anticoagulants Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Intravenous Anticoagulants Production Value by Region (2017-2022) & (USD Million)
Table 3. World Intravenous Anticoagulants Production Value by Region (2023-2028) & (USD Million)
Table 4. World Intravenous Anticoagulants Production Value Market Share by Region (2017-2022)
Table 5. World Intravenous Anticoagulants Production Value Market Share by Region (2023-2028)
Table 6. World Intravenous Anticoagulants Production by Region (2017-2022) & (K Units)
Table 7. World Intravenous Anticoagulants Production by Region (2023-2028) & (K Units)
Table 8. World Intravenous Anticoagulants Production Market Share by Region (2017-2022)
Table 9. World Intravenous Anticoagulants Production Market Share by Region (2023-2028)
Table 10. World Intravenous Anticoagulants Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Intravenous Anticoagulants Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Intravenous Anticoagulants Major Market Trends
Table 13. World Intravenous Anticoagulants Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Intravenous Anticoagulants Consumption by Region (2017-2022) & (K Units)
Table 15. World Intravenous Anticoagulants Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Intravenous Anticoagulants Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Intravenous Anticoagulants Producers in 2021
Table 18. World Intravenous Anticoagulants Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Intravenous Anticoagulants Producers in 2021
Table 20. World Intravenous Anticoagulants Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Intravenous Anticoagulants Company Evaluation Quadrant
Table 22. World Intravenous Anticoagulants Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Intravenous Anticoagulants Production Site of Key Manufacturer
Table 24. Intravenous Anticoagulants Market: Company Product Type Footprint
Table 25. Intravenous Anticoagulants Market: Company Product Application Footprint
Table 26. Intravenous Anticoagulants Competitive Factors
Table 27. Intravenous Anticoagulants New Entrant and Capacity Expansion Plans
Table 28. Intravenous Anticoagulants Mergers & Acquisitions Activity
Table 29. United States VS China Intravenous Anticoagulants Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Intravenous Anticoagulants Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Intravenous Anticoagulants Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Intravenous Anticoagulants in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Intravenous Anticoagulants Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Intravenous Anticoagulants Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Intravenous Anticoagulants Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Intravenous Anticoagulants Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Intravenous Anticoagulants in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Intravenous Anticoagulants Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Intravenous Anticoagulants Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Intravenous Anticoagulants Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Intravenous Anticoagulants Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Intravenous Anticoagulants in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Intravenous Anticoagulants Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Intravenous Anticoagulants Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Intravenous Anticoagulants Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Intravenous Anticoagulants Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Intravenous Anticoagulants Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Intravenous Anticoagulants Production by Type (2017-2022) & (K Units)
Table 49. World Intravenous Anticoagulants Production by Type (2023-2028) & (K Units)
Table 50. World Intravenous Anticoagulants Production Value by Type (2017-2022) & (USD Million)
Table 51. World Intravenous Anticoagulants Production Value by Type (2023-2028) & (USD Million)
Table 52. World Intravenous Anticoagulants Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Intravenous Anticoagulants Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Intravenous Anticoagulants Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Intravenous Anticoagulants Production by Application (2017-2022) & (K Units)
Table 56. World Intravenous Anticoagulants Production by Application (2023-2028) & (K Units)
Table 57. World Intravenous Anticoagulants Production Value by Application (2017-2022) & (USD Million)
Table 58. World Intravenous Anticoagulants Production Value by Application (2023-2028) & (USD Million)
Table 59. World Intravenous Anticoagulants Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Intravenous Anticoagulants Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Aspen Group Basic Information, Manufacturing Base and Competitors
Table 62. Aspen Group Major Business
Table 63. Aspen Group Intravenous Anticoagulants Product and Services
Table 64. Aspen Group Intravenous Anticoagulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Aspen Group Recent Developments/Updates
Table 66. Aspen Group Competitive Strengths & Weaknesses
Table 67. Pfizer Basic Information, Manufacturing Base and Competitors
Table 68. Pfizer Major Business
Table 69. Pfizer Intravenous Anticoagulants Product and Services
Table 70. Pfizer Intravenous Anticoagulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Pfizer Recent Developments/Updates
Table 72. Pfizer Competitive Strengths & Weaknesses
Table 73. Sanofi Basic Information, Manufacturing Base and Competitors
Table 74. Sanofi Major Business
Table 75. Sanofi Intravenous Anticoagulants Product and Services
Table 76. Sanofi Intravenous Anticoagulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Sanofi Recent Developments/Updates
Table 78. Sanofi Competitive Strengths & Weaknesses
Table 79. Mylan Basic Information, Manufacturing Base and Competitors
Table 80. Mylan Major Business
Table 81. Mylan Intravenous Anticoagulants Product and Services
Table 82. Mylan Intravenous Anticoagulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Mylan Recent Developments/Updates
Table 84. Mylan Competitive Strengths & Weaknesses
Table 85. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 86. Bayer AG Major Business
Table 87. Bayer AG Intravenous Anticoagulants Product and Services
Table 88. Bayer AG Intravenous Anticoagulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Bayer AG Recent Developments/Updates
Table 90. Bayer AG Competitive Strengths & Weaknesses
Table 91. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 92. Boehringer Ingelheim Major Business
Table 93. Boehringer Ingelheim Intravenous Anticoagulants Product and Services
Table 94. Boehringer Ingelheim Intravenous Anticoagulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Boehringer Ingelheim Recent Developments/Updates
Table 96. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 97. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 98. Daiichi Sankyo Major Business
Table 99. Daiichi Sankyo Intravenous Anticoagulants Product and Services
Table 100. Daiichi Sankyo Intravenous Anticoagulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Daiichi Sankyo Recent Developments/Updates
Table 102. Daiichi Sankyo Competitive Strengths & Weaknesses
Table 103. Otsuka Basic Information, Manufacturing Base and Competitors
Table 104. Otsuka Major Business
Table 105. Otsuka Intravenous Anticoagulants Product and Services
Table 106. Otsuka Intravenous Anticoagulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Otsuka Recent Developments/Updates
Table 108. Otsuka Competitive Strengths & Weaknesses
Table 109. Roche Basic Information, Manufacturing Base and Competitors
Table 110. Roche Major Business
Table 111. Roche Intravenous Anticoagulants Product and Services
Table 112. Roche Intravenous Anticoagulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Roche Recent Developments/Updates
Table 114. Roche Competitive Strengths & Weaknesses
Table 115. The Medicines Company Basic Information, Manufacturing Base and Competitors
Table 116. The Medicines Company Major Business
Table 117. The Medicines Company Intravenous Anticoagulants Product and Services
Table 118. The Medicines Company Intravenous Anticoagulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. The Medicines Company Recent Developments/Updates
Table 120. The Medicines Company Competitive Strengths & Weaknesses
Table 121. Alexion Basic Information, Manufacturing Base and Competitors
Table 122. Alexion Major Business
Table 123. Alexion Intravenous Anticoagulants Product and Services
Table 124. Alexion Intravenous Anticoagulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Alexion Recent Developments/Updates
Table 126. Leo Pharma Basic Information, Manufacturing Base and Competitors
Table 127. Leo Pharma Major Business
Table 128. Leo Pharma Intravenous Anticoagulants Product and Services
Table 129. Leo Pharma Intravenous Anticoagulants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 130. Intravenous Anticoagulants Raw Material
Table 131. Key Manufacturers of Intravenous Anticoagulants Raw Materials
Table 132. Intravenous Anticoagulants Typical Distributors
Table 133. Intravenous Anticoagulants Typical Customers

LIST OF FIGURES

Figure 1. Intravenous Anticoagulants Picture
Figure 2. World Intravenous Anticoagulants Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Intravenous Anticoagulants Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Intravenous Anticoagulants Production (2017-2028) & (K Units)
Figure 5. World Intravenous Anticoagulants Average Price (2017-2028) & (US$/Unit)
Figure 6. World Intravenous Anticoagulants Production Value Market Share by Region (2017-2028)
Figure 7. World Intravenous Anticoagulants Production Market Share by Region (2017-2028)
Figure 8. North America Intravenous Anticoagulants Production (2017-2028) & (K Units)
Figure 9. Europe Intravenous Anticoagulants Production (2017-2028) & (K Units)
Figure 10. China Intravenous Anticoagulants Production (2017-2028) & (K Units)
Figure 11. Japan Intravenous Anticoagulants Production (2017-2028) & (K Units)
Figure 12. Intravenous Anticoagulants Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Intravenous Anticoagulants Demand (2017-2028) & (K Units)
Figure 15. World Intravenous Anticoagulants Consumption Market Share by Region (2017-2028)
Figure 16. United States Intravenous Anticoagulants Consumption (2017-2028) & (K Units)
Figure 17. China Intravenous Anticoagulants Consumption (2017-2028) & (K Units)
Figure 18. Europe Intravenous Anticoagulants Consumption (2017-2028) & (K Units)
Figure 19. Japan Intravenous Anticoagulants Consumption (2017-2028) & (K Units)
Figure 20. South Korea Intravenous Anticoagulants Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Intravenous Anticoagulants Consumption (2017-2028) & (K Units)
Figure 22. India Intravenous Anticoagulants Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Intravenous Anticoagulants by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Intravenous Anticoagulants Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Intravenous Anticoagulants Markets in 2021
Figure 26. United States VS China: Intravenous Anticoagulants Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Intravenous Anticoagulants Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Intravenous Anticoagulants Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Intravenous Anticoagulants in United States
Figure 30. Key Producers and Market Share of Intravenous Anticoagulants in China
Figure 31. Key Producers and Market Share of Intravenous Anticoagulants in Rest of World
Figure 32. World Intravenous Anticoagulants Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Intravenous Anticoagulants Production Value Market Share by Type in 2021
Figure 34. Low-Molecular-Weight Heparin (LMWH)
Figure 35. Direct Thrombin Inhibitor (DTI)
Figure 36. Others
Figure 37. World Intravenous Anticoagulants Production Market Share by Type (2017-2028)
Figure 38. World Intravenous Anticoagulants Production Value Market Share by Type (2017-2028)
Figure 39. World Intravenous Anticoagulants Average Price by Type (2017-2028) & (US$/Unit)
Figure 40. World Intravenous Anticoagulants Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 41. World Intravenous Anticoagulants Production Value Market Share by Application in 2021
Figure 42. Hospital
Figure 43. Clinic
Figure 44. Others
Figure 45. World Intravenous Anticoagulants Production Market Share by Application (2017-2028)
Figure 46. World Intravenous Anticoagulants Production Value Market Share by Application (2017-2028)
Figure 47. World Intravenous Anticoagulants Average Price by Application (2017-2028) & (US$/Unit)
Figure 48. Manufacturing Cost Structure Analysis of Intravenous Anticoagulants in 2021
Figure 49. Manufacturing Process Analysis of Intravenous Anticoagulants
Figure 50. Intravenous Anticoagulants Industrial Chain
Figure 51. Distribution Channel Breakdown for Intravenous Anticoagulants Shipments (%): 2017-2028
Figure 52. Direct Channel Pros & Cons
Figure 53. Indirect Channel Pros & Cons
Figure 54. Methodology
Figure 55. Research Process and Data Source


More Publications